Newborns with high bilirubin levels face a serious risk of brain damage. This condition is called neonatal hyperbilirubinemia. A recent meta-analysis looked at a specific treatment called oral zinc sulfate. Researchers combined data from many studies involving 1,405 infants. They wanted to see if this simple supplement could lower bilirubin levels safely. The results showed a clear benefit. Bilirubin levels dropped significantly at 24 hours, 48 hours, 72 hours, and four days. The reduction was consistent across all time points measured. This means the treatment works quickly to clear the yellow tint from a baby's skin and eyes.
However, the data has important caveats. The analysis found high differences between the studies included. This is known as heterogeneity. It suggests that results might vary depending on the specific setting or patient group. The study did not report safety data or side effects. We cannot assume the treatment is safe just because no problems were listed. The evidence only supports the use of zinc sulfate for lowering bilirubin in infants with this specific condition.
The takeaway is clear but limited. Oral zinc sulfate reduces bilirubin levels in newborns. Doctors should weigh this benefit against the lack of safety information. More research is needed to confirm if this approach is safe for all babies.
